Caveolin-1 and dopamine-mediated internalization of nakatpase in human renal proximal tubule cells

Hypertension

Volumn 54, Issue 5, 2009, Pages 1070-1076

  Gildea, John J ^a   Israel, Jonathan A ^a   Johnson, Andrew K ^a   Zhang, Jin ^c   Jose, Pedro A ^b   Felder, Robin A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Caveolin; Dopamine receptors; FRET; GRK4; Hypertension; NaKATPase; Proximal tubule

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENYLATE CYCLASE; CAVEOLIN 1; DOPAMINE 1 RECEPTOR; FENOLDOPAM; G PROTEIN COUPLED RECEPTOR KINASE 4; SMALL INTERFERING RNA; CYCLIC AMP;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANALYSIS OF VARIANCE; CELL CULTURE; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG EFFECT; METABOLISM; PROBABILITY;

ANALYSIS OF VARIANCE; CAVEOLIN 1; CELLS, CULTURED; CYCLIC AMP; ENZYME-LINKED IMMUNOSORBENT ASSAY; FENOLDOPAM; G-PROTEIN-COUPLED RECEPTOR KINASE 4; HUMANS; KIDNEY TUBULES, PROXIMAL; MICROSCOPY, CONFOCAL; PROBABILITY; RECEPTORS, DOPAMINE D1; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 70449700143     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.134338     Document Type: Article

References (58)

1. Siragy HM, Felder RA, Howell NE, Chevalier RL, Peach MJ, Carey RM. Intrarenal dopamine acts at the dopamine-1 receptor to control renal function. J Hypertens. 1988;6(suppl):S479-S481.
2. Siragy HM, Felder RA, Howell NL, Chevalier RL, Peach MJ, Carey RM. Intrarenal dopamine-1 receptors control renal function. Trans Assoc Am Physicians. 1988;101:288-291.
3. Jose PA, Asico LD, Eisner GM, Pocchiari F, Semeraro C, Felder RA. Effects of costimulation of dopamine D1-and D2-like receptors on renal function. Am J Physiol. 1998;275:R986-R994.
4. Hedge SS, Ricci A, Amenta F, Lokhandwala MF. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam. J Pharmacol Exp Ther. 1989;251:1237-1245.
5. Zeng C, Armando I, Luo Y, Eisner GM, Felder RA, Jose PA. Dysregu-lation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol. 2008;294:H551-H569.
6. Chen CJ, Lokhandwala MF. An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin Exp Hypertens A. 1992;14:615-628.
7. Olsen NV. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans. Dan Med Bull. 1998;45: 282-297.
8. O'Connell DP, Ragsdale NV, Boyd DG, Felder RA, Carey RM. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension. 1997;29: 115-122.
9. Haney M, Ward AS, Foltin RW, Fischman MW. Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology (Berl). 2001;155:330-337.
10. Hu MC, Fan L, Crowder LA, Karim-Jimenez Z, Murer H, Moe OW. Dopamine acutely stimulates Na+/H+ exchanger (NHE3) endocytosis via clathrin-coated vesicles: dependence on protein kinase A-mediated NHE3 phosphorylation. J Biol Chem. 2001;276:26906-26915.
11. Felder CC, Campbell T, Albrecht F, Jose PA. Dopamine inhibits Na( + )-H+ exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol. 1990;259:F297-F303.
12. Trivedi M, Narkar VA, Hussain T, Lokhandwala MF. Dopamine recruits D1A receptors to Na-K-ATPase-rich caveolar plasma membranes in rat renal proximal tubules. Am J Physiol Renal Physiol. 2004;287: F921-F931.
13. Efendiev R, Das-Panja K, Cinelli AR, Bertorello AM, Pedemonte CH. Localization of intracellular compartments that exchange Na,K-ATPase molecules with the plasma membrane in a hormone-dependent manner. Br J Pharmacol. 2007;151:1006-1013.
14. Pedemonte CH, Efendiev R, Bertorello AM. Inhibition of Na,K-ATPase by dopamine in proximal tubule epithelial cells. Semin Nephrol. 2005; 25:322-327.
15. Yudowski GA, Efendiev R, Pedemonte CH, Katz AI, Berggren PO, Bertorello AM. Phosphoinositide-3 kinase binds to a proline-rich motif in the Na +, K +-ATPase alpha subunit and regulates its trafficking. Proc Natl Acad Sci USA. 2000;97:6556-6561.
16. Efendiev R, Budu CE, Cinelli AR, Bertorello AM, Pedemonte CH. Intracellular Na+ regulates dopamine and angiotensin II receptors availability at the plasma membrane and their cellular responses in renal epithelia. J Biol Chem. 2003;278:28719-28726.
17. Efendiev R, Krmar RT, Ogimoto G, Zwiller J, Tripodi G, Katz AI, Bianchi G, Pedemonte CH, Bertorello AM. Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na +,K +-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ Res. 2004;95:1100-1108.
18. Cinelli AR, Efendiev R, Pedemonte CH. Trafficking of Na-K-ATPase and dopamine receptor molecules induced by changes in intracellular sodium concentration of renal epithelial cells. Am J Physiol Renal Physiol. 2008;295:F1117-F1125.
19. Dostanic-Larson I, Lorenz JN, Van Huysse JW, Neumann JC, Moseley AE, Lingrel JB. Physiological role of the alpha1-and alpha2-isoforms of the Na +-K +-ATPase and biological significance of their cardiac glycoside binding site. Am J Physiol Regul Integr Comp Physiol. 2006;290: R524-R528.
20. Li Z, Rodriguez-Iturbe B, Ni Z, Shahkarami A, Sepassi L, Vaziri ND. Effect of hereditary obesity on renal expressions of NO synthase, caveolin-1, AKt, guanylate cyclase, and calmodulin. Kidney Int. 2005; 68:2766-2772.
21. Liu J, Liang M, Liu L, Malhotra D, Xie Z, Shapiro JI. Ouabain-induced endocytosis of the plasmalemmal Na/K-ATPase in LLC-PK1 cells requires caveolin-1. Kidney Int. 2005;67:1844-1854. (Pubitemid 40577720)
22. Liu J, Shapiro JI. Regulation of sodium pump endocytosis by cardiotonic steroids: molecular mechanisms and physiological implications. Pathophysiology. 2007;14:171-181.
23. Lisanti MP, Scherer PE, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu YH, Cook RF, Sargiacomo M. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol. 1994;126:111-126.
24. Patel HH, Murray F, Insel PA. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol. 2008;48:359-391.
25. Yu P, Yang Z, Asico L, Hopfer U, Felder R, Jose P. Redistribution of caveolin-2 in the response to D1-like receptor stimulation in immortalized renal proximal tubule cells. Mol Biol Cell. 2000;11:551.
26. Yu P, Yang Z, Jones JE, Wang Z, Owens SA, Mueller SC, Felder RA, Jose PA. D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int. 2004;66:2167-2180.
27. Felder RA, Jose PA. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol. 2006;2:637-650.
28. Watanabe H, Xu J, Bengra C, Jose PA, Felder RA. Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int. 2002;62:790-798. (Pubitemid 35316708)
29. Felder RA, Seikaly MG, Cody P, Eisner GM, Jose PA. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension. 1990;15:560-569.
30. Lokhandwala MF, Hussain T. Defective renal dopamine D1-like receptor signal transduction in obese hypertensive rats. Acta Physiol Scand. 2000; 168:251-255.
31. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong LJ, Robillard JE, Carey RM, Eisner GM, Jose PA. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA. 2002;99:3872-3877.
32. Kinoshita S, Sidhu A, Felder RA. Defective dopamine-1 receptor ade-nylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest. 1989;84:1849-1856.
33. Felder RA, Eisner GM, Jose PA. D1 dopamine receptor signalling defect in spontaneous hypertension. Acta Physiol Scand. 2000;168:245-250.
34. Sanada H, Jose PA, Hazen-Martin D, Yu PY, Xu J, Bruns DE, Phipps J, Carey RM, Felder RA. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension. 1999;33:1036-1042.
35. Gildea JJ, Wang X, Jose PA, Felder RA. Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. Hypertension. 2008;51:360-366.
36. Han W, Li H, Villar VA, Pascua AM, Dajani MI, Wang X, Natarajan A, Quinn MT, Felder RA, Jose PA, Yu P. Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells. Hypertension. 2008;51:481-487.
37. Violin JD, DiPilato LM, Yildirim N, Elston TC, Zhang J, Lefkowitz RJ. Beta2-adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics. J Biol Chem. 2008; 283:2949-2961.
38. Gilad LA, Schwartz B. Association of estrogen receptor beta with plasma-membrane caveola components: implication in control of vitamin D receptor. J Mol Endocrinol. 2007;38:603-618.
39. Carman CV, Lisanti MP, Benovic JL. Regulation of G protein-coupled receptor kinases by caveolin. J Biol Chem. 1999;274:8858-8864.
40. Grilo A, Fernandez ML, Beltran M, Ramirez-Lorca R, Gonzalez MA, Royo JL, Gutierrez-Tous R, Moron FJ, Couto C, Serrano-Rios M, Saez ME, Ruiz A, Real LM. Genetic analysis of CAV1 gene in hypertension and metabolic syndrome. Thromb Haemost. 2006;95:696-701.
41. Ribas C, Penela P, Murga C, Salcedo A, Garcia-Hoz C, Jurado-Pueyo M, Aymerich I, Mayor F Jr. The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta. 2007;1768:913-922.
42. Gildea JJ, Yatabe J, Sasaki M, Jose PA, Felder RA. G-protein coupled receptor kinase 4 (GRK4) polymorphisms block receptor recruitment to cell membranes. Hypertension. 2006;48:e85.
43. Zeng C, Luo Y, Asico LD, Hopfer U, Eisner GM, Felder RA, Jose PA. Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension. 2003;42:787-792.
44. Wang Z, Asico LD, Escano CS, Felder RA, Jose PA. Human G protein-coupled receptor kinase type 4 g (hGRK4g) wild-type prevents salt sensitivity while its variant, hGRK4g486V, promotes salt sensitivity in transgenic mice: role of genetic background. Hypertension. 2006;48:e27.
45. Wang Z, Zeng C, Asico L, Felder RA, Jose PA. The role of GRK4gA142V in the dysfunction of renal AT1 and D1 dopamine receptor in genetic hypertension. Circulation. 2005;112:187.
46. Albrecht FE, Drago J, Felder RA, Printz MP, Eisner GM, Robillard JE, Sibley DR, Westphal HJ, Jose PA. Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest. 1996;97: 2283-2288.
47. Li XX, Xu J, Zheng S, Albrecht FE, Robillard JE, Eisner GM, Jose PA. D(1) dopamine receptor regulation of NHE3 during development in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1650-R1656.
48. Xu J, Li XX, Albrecht FE, Hopfer U, Carey RM, Jose PA. Dopamine(1) receptor, G(salpha), and Na( + )-H( + ) exchanger interactions in the kidney in hypertension. Hypertension. 2000;36:395-399.
49. GesekFA, Schoolwerth AC. Hormone responses of proximal Na( + )-H + exchanger in spontaneously hypertensive rats. Am J Physiol. 1991;261: F526-F536.
50. Kunimi M, Seki G, Hara C, Taniguchi S, Uwatoko S, Goto A, Kimura S, Fujita T. Dopamine inhibits renal Na+:HCO3-cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats. Kidney Int. 2000;57:534-543.
51. Pedrosa R, Jose PA, Soares-da-Silva P. Defective D1-like receptor-mediated inhibition of the Cl-/HCO3-exchanger in immortalized SHR proximal tubular epithelial cells. Am J Physiol Renal Physiol. 2004;286: F1120-F1126.
52. Nishi A, Eklof AC, Bertorello AM, Aperia A. Dopamine regulation of renal Na +,K( + )-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension. 1993;21:767-771. (Pubitemid 23171638)
53. Hussain T, Lokhandwala MF. Renal dopamine DA1 receptor coupling with G(S) and G(q/11) proteins in spontaneously hypertensive rats. Am J Physiol. 1997;272:F339-F346.
54. Chen C, Beach RE, Lokhandwala MF. Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats. Hypertension. 1993;21: 364-372.
55. Lucas-Teixeira VA, Vieira-Coelho MA, Serrao P, Pestana M, Soares-da-Silva P. Salt intake and sensitivity of intestinal and renal Na +-K + atpase to inhibition by dopamine in spontaneous hypertensive and Wistar-Kyoto rats. Clin Exp Hypertens. 2000;22:455-469.
56. Debska-Slizien A, Ho P, Drangova R, Baines AD. Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys. J Am Soc Nephrol. 1994;5:1125-1132.
57. Efendiev R, Chen Z, Krmar RT, Uhles S, Katz AI, Pedemonte CH, Bertorello AM. The 14-3-3 protein translates the NA +,K +-ATPase {alpha}1-subunit phosphorylation signal into binding and activation of phosphoinositide 3-kinase during endocytosis. J Biol Chem. 2005;280: 16272-16277.
58. Hinojos CA, Doris PA. Altered subcellular distribution of Na +,K +-ATPase in proximal tubules in young spontaneously hypertensive rats. Hypertension. 2004;44:95-100